𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Validation of the lymph node ratio as a prognostic factor in patients with N1 nonsmall cell lung cancer

✍ Scribed by Sirisha Jonnalagadda; Jacqueline Arcinega; Cardinale Smith; Juan P. Wisnivesky

Publisher
John Wiley and Sons
Year
2011
Tongue
English
Weight
327 KB
Volume
117
Category
Article
ISSN
0008-543X

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Frequency of noncontiguous lymph node in
Frequency of noncontiguous lymph node involvement in patients with resectable nonsmall cell lung carcinoma
✍ James A. Bonner; Yolanda I. Garces; Timothy E. Sawyer; Perry M. Gould; Robert L. πŸ“‚ Article πŸ“… 1999 πŸ› John Wiley and Sons 🌐 English βš– 71 KB πŸ‘ 1 views

This study was undertaken to investigate the patterns of lymph node spread and the frequency of involvement of noncontiguous lymph node stations in patients with nonsmall cell lung carcinoma who had complete surgical resection. ## METHODS. All patients who had surgical resection as their sole trea

ERCC1 expression as a prognostic marker
ERCC1 expression as a prognostic marker in N2(+) nonsmall-cell lung cancer patients treated with platinum-based neoadjuvant concurrent chemoradiotherapy
✍ In Gyu Hwang; Myung Ju Ahn; Byeong Bae Park; Yong Chan Ahn; Joungho Han; Seungko πŸ“‚ Article πŸ“… 2008 πŸ› John Wiley and Sons 🌐 English βš– 185 KB πŸ‘ 1 views

## Abstract ## BACKGROUND. Excision repair cross‐complementation Group 1 (__ERCC1__) overexpression is associated with resistance to cisplatin‐based chemotherapy in patients with nonsmall‐cell lung cancer (NSCLC). A preliminary study also suggested that __ERCC1__ expression is associated with radi

Prognostic model to predict outcomes in
Prognostic model to predict outcomes in nonsmall cell lung cancer patients treated with gefitinib as a salvage treatment
✍ Min Jae Park; Jeeyun Lee; Jung Yong Hong; Moon Ki Choi; Joon Ho Yi; Su Jin Lee; πŸ“‚ Article πŸ“… 2009 πŸ› John Wiley and Sons 🌐 English βš– 437 KB πŸ‘ 2 views

## Abstract ## BACKGROUND: A prognostic model based on clinical parameters for nonsmall cell lung cancer (NSCLC) patients treated with gefitinib (250 mg/day) as a salvage therapy was devised. ## METHODS: Clinical data regarding a total of 316 metastatic or recurrent NSCLC patients who were treat

Autologous tumor killing activity as a p
Autologous tumor killing activity as a prognostic factor in primary resected nonsmall cell carcinoma of the lung
✍ Takehiko Fujisawa; Yutaka Yamaguchi πŸ“‚ Article πŸ“… 1997 πŸ› John Wiley and Sons 🌐 English βš– 126 KB πŸ‘ 2 views

## Background: Cytotoxic activity of peripheral blood lymphocytes obtained during surgery against autologous fresh tumor cells has been reported. however, the role of lymphocyte autologous tumor killing or natural killer activity during the postoperative period remains obscure. in this article, the